![]() |
市場調査レポート
商品コード
1623871
医療ガスの市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測、2025~2032年Medical Gas Market Size, Share, Growth Analysis, By Product (Pure Gases, Gas Mixtures), By Application (Therapeutic, Diagnostics), By End Use, By Region - Industry Forecast 2025-2032 |
||||||
|
医療ガスの市場規模、シェア、成長分析、製品別、用途別、最終用途別、地域別 - 産業予測、2025~2032年 |
出版日: 2024年12月26日
発行: SkyQuest
ページ情報: 英文 165 Pages
納期: 3~5営業日
|
医療ガスの世界市場規模は2023年に134億米ドルと評価され、予測期間(2025-2032年)のCAGRは7.8%で、2024年の151億米ドルから2032年には263億4,000万米ドルに成長する見通しです。
医療ガス市場は、慢性呼吸器疾患(CRDs)の有病率の上昇、政府によるヘルスケアへの取り組み、在宅ヘルスケアやポイントオブケア製品の需要を高める高齢化によって大きな成長を遂げています。COPDのような疾患に関連した死亡者は年間300万人を超え、酸素と関連する医療ガスの必要性はかつてないほど高まっています。COVID-19の大流行はこの需要をさらに悪化させ、液体医療用酸素の使用量をかつてないほど急増させ、インドでの需要は1日当たり5,000トンにまで急増しました。さらに、医療ガス容器の安全性向上と識別を目的としたFDAの規制が市場の成長を後押しすると予想されます。在宅ヘルスケア・サービスの動向とFDA認可の増加は、医療ガスの持続的需要を約束し、今後数年間は不可欠な分野となります。
Global Medical Gas Market size was valued at USD 13.4 billion in 2023 and is poised to grow from USD 15.1 billion in 2024 to USD 26.34 billion by 2032, growing at a CAGR of 7.8% during the forecast period (2025-2032).
The medical gases market is experiencing significant growth driven by the rising prevalence of chronic respiratory diseases (CRDs), government healthcare initiatives, and an aging population that increases the demand for home healthcare and point-of-care products. With over 3 million deaths linked to conditions like COPD annually, the need for oxygen and related medical gases is at an all-time high. The COVID-19 pandemic exacerbated this demand, leading to unprecedented spikes in liquid medicinal oxygen usage, with demand in India soaring to 5,000 tonnes per day. Furthermore, FDA regulations aimed at improving the safety and identification of medical gas containers are expected to bolster market growth. The trend toward at-home healthcare services and increasing FDA approvals promise a sustained demand for medical gases, making it an essential sector in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Gas market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Gas Market Segmental Analysis
Global Medical Gas Market is segmented by product, application, end use and region. Based on product, the market is segmented into pure gases and gas mixtures. Based on application, the market is segmented into therapeutic, diagnostics, pharmaceutical manufacturing and others. Based on end use, the market is segmented into hospitals, ambulatory surgical centers, home healthcare, pharmaceutical and biotechnology companies, diagnostic and research laboratories and academic and research institutions. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Medical Gas Market
The global medical gas market is strongly influenced by the rising prevalence of obesity and associated health issues, which have surged in recent years due to lifestyle and dietary changes. Between 2021 and 2022, obesity rates escalated significantly, with the World Health Organization (WHO) reporting over 1.9 billion adults aged 18 and older classified as overweight in 2021, of which over 650 million were obese. Additionally, around 340 million children and adolescents aged 5 to 19 were identified as overweight or obese. Obesity is a primary contributor to the increasing occurrence of chronic diseases, including diabetes and heart disease, both of which have seen substantial growth over the last two decades. The American Hospital Association highlighted that in 2021, 149 million individuals in the U.S. were affected by at least one chronic illness, a number expected to reach 171 million by 2028. This alarming rise in lifestyle-related diseases is projected to drive the growth of the medical gases and equipment market significantly, as these gases are vital for the management of various chronic conditions, including respiratory diseases and cancer.
Restraints in the Global Medical Gas Market
The Global Medical Gas market faces a significant constraint due to the critical role of helium, primarily used in medical imaging and as a carrier gas in various analytical procedures. With over 20% of helium consumption linked to medical applications, the reliance on U.S. helium production becomes problematic. The vast majority of helium globally comes from the U.S. federal reserve, managed by the Bureau of Land Management. Legislative changes in 2021 aimed at gradually depleting this reserve at higher costs create uncertainty in helium availability, leading to a 5-10% shortfall for essential applications like MRI and defense. As helium prices are anticipated to rise, manufacturers are compelled to seek alternative cooling gases, which could negatively impact the overall medicinal gas market.
Market Trends of the Global Medical Gas Market
The Global Medical Gas market is witnessing significant growth, driven by the implementation of the FDA Safety and Innovation Act, which empowers manufacturers to innovate and control costs for medical gases and equipment. The shift towards home healthcare, coupled with an aging population and increasing urbanization, has further propelled demand. However, challenges such as helium shortages, evolving calibration standards, and reduced governmental reimbursements for respiratory therapies may restrain growth. Conversely, emerging markets present lucrative opportunities, alongside advancements in medical research technologies, positioning the market for resilience and expansion in the coming years.